Tornier, LifeCell in pig-tissue matrix pact
This article was originally published in Clinica
Executive Summary
Extremity orthopaedics specialist Tornier has teamed up with regenerative human tissue company LifeCell, to distribute the latter's new-generation reconstructive tissue matrix. The exclusive deal, of which no financial details were disclosed, will see the two firms work together to develop the product for orthopaedic soft tissue repair applications such as tendon repair. Tornier will then distribute the product to orthopaedic and podiatric surgeons under the brand name Conexa. The product is already approved by the FDA for these applications. The new tissue matrix uses porcine-derived tissue technology which, according to Edina, Minnesota-based Tornier, is equally as effective at promoting tissue regeneration as the company's flagship human tissue matrix, AlloDerm.